These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 33386466)

  • 1. The subtle interplay between gamma delta T lymphocytes and dendritic cells: is there a role for a therapeutic cancer vaccine in the era of combinatorial strategies?
    Galati D; Zanotta S; Bocchino M; De Filippi R; Pinto A
    Cancer Immunol Immunother; 2021 Jul; 70(7):1797-1809. PubMed ID: 33386466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empowering dendritic cell cancer vaccination: the role of combinatorial strategies.
    Galati D; Zanotta S
    Cytotherapy; 2018 Nov; 20(11):1309-1323. PubMed ID: 30360963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced ability of dendritic cells to stimulate innate and adaptive immunity on short-term incubation with zoledronic acid.
    Fiore F; Castella B; Nuschak B; Bertieri R; Mariani S; Bruno B; Pantaleoni F; Foglietta M; Boccadoro M; Massaia M
    Blood; 2007 Aug; 110(3):921-7. PubMed ID: 17403919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells.
    Schnurr M; Scholz C; Rothenfusser S; Galambos P; Dauer M; Röbe J; Endres S; Eigler A
    Cancer Res; 2002 Apr; 62(8):2347-52. PubMed ID: 11956095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic Cells Are Critical for the Activation and Expansion of Vδ2
    Wang X; Liu J; Gao H; Mo XD; Han T; Xu LP; Zhang XH; Huang XJ
    Front Immunol; 2018; 9():2528. PubMed ID: 30443256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell cross talk with innate and innate-like effector cells in antitumor immunity: implications for DC vaccination.
    van Beek JJ; Wimmers F; Hato SV; de Vries IJ; Sköld AE
    Crit Rev Immunol; 2014; 34(6):517-36. PubMed ID: 25597314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune suppression by gammadelta T-cells as a potential regulatory mechanism after cancer vaccination with IL-12 secreting dendritic cells.
    Traxlmayr MW; Wesch D; Dohnal AM; Funovics P; Fischer MB; Kabelitz D; Felzmann T
    J Immunother; 2010 Jan; 33(1):40-52. PubMed ID: 19952957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy.
    Liu Y; Zhang C
    Cells; 2020 May; 9(5):. PubMed ID: 32413966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The plasticity of gamma delta T cells: innate immunity, antigen presentation and new immunotherapy.
    Casetti R; Martino A
    Cell Mol Immunol; 2008 Jun; 5(3):161-70. PubMed ID: 18582397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-15-Cultured Dendritic Cells Enhance Anti-Tumor Gamma Delta T Cell Functions through IL-15 Secretion.
    Van Acker HH; Anguille S; De Reu H; Berneman ZN; Smits EL; Van Tendeloo VF
    Front Immunol; 2018; 9():658. PubMed ID: 29692776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune modulation by zoledronic acid in human myeloma: an advantageous cross-talk between Vγ9Vδ2 T cells, αβ CD8+ T cells, regulatory T cells, and dendritic cells.
    Castella B; Riganti C; Fiore F; Pantaleoni F; Canepari ME; Peola S; Foglietta M; Palumbo A; Bosia A; Coscia M; Boccadoro M; Massaia M
    J Immunol; 2011 Aug; 187(4):1578-90. PubMed ID: 21753152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-derived γδ regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence.
    Ye J; Ma C; Hsueh EC; Eickhoff CS; Zhang Y; Varvares MA; Hoft DF; Peng G
    J Immunol; 2013 Mar; 190(5):2403-14. PubMed ID: 23355732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Function of γδ T cells in tumor immunology and their application to cancer therapy.
    Park JH; Lee HK
    Exp Mol Med; 2021 Mar; 53(3):318-327. PubMed ID: 33707742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer immunotherapy with γδ T cells: many paths ahead of us.
    Kabelitz D; Serrano R; Kouakanou L; Peters C; Kalyan S
    Cell Mol Immunol; 2020 Sep; 17(9):925-939. PubMed ID: 32699351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Vγ9/Vδ2 T cells: Innate adaptors of the immune system.
    Tyler CJ; Doherty DG; Moser B; Eberl M
    Cell Immunol; 2015 Jul; 296(1):10-21. PubMed ID: 25659480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zoledronate-activated Vγ9γδ T cell-based immunotherapy is feasible and restores the impairment of γδ T cells in patients with solid tumors.
    Noguchi A; Kaneko T; Kamigaki T; Fujimoto K; Ozawa M; Saito M; Ariyoshi N; Goto S
    Cytotherapy; 2011 Jan; 13(1):92-7. PubMed ID: 20831354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression.
    Stolk D; van der Vliet HJ; de Gruijl TD; van Kooyk Y; Exley MA
    Front Immunol; 2018; 9():1990. PubMed ID: 30298063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting.
    Li Y; Li G; Zhang J; Wu X; Chen X
    Front Immunol; 2020; 11():619954. PubMed ID: 33664732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses.
    Brandes M; Willimann K; Bioley G; Lévy N; Eberl M; Luo M; Tampé R; Lévy F; Romero P; Moser B
    Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2307-12. PubMed ID: 19171897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.